Fibrous dysplasia (FD) is sometimes accompanied by extraskeletal manifestations that can include any combination of café-au-lait macules, hyperfunctioning endocrinopathies, such as gonadotropin-independent precocious puberty, hyperthyroidism, growth hormone excess, FGF23-mediated renal phosphate wasting, and/or Cushing's syndrome, as well as other less common features. The combination of any of these findings, with or without FD, is known as McCuneAlbright syndrome (MAS). The broad spectrum of involved tissues and the unpredictable combination of findings is because of a molecular defect due to dominant activating mutations in the widely expressed signalling protein Gsα. These mutations arise sporadically, often early in development, prior to gastrulation and can distribute across many or few tissues.
INTRODUCTION
McCune-Albright Syndrome is a rare, heterogenous disorder caused by a sporadic, somatic, post-zygotic mutation in GNAS. It is most commonly manifested as the triad of polyostotic fibrous dysplasia, café-au-lait hyperpigmentation along with hyperfunctional endocrinopathies. 2, 3 The syndrome has a female predilection 1 with an estimated prevalence between 1/100,000 and 1/1,000,000. 4 The most easily visually assessed feature is café-au-lait skin pigmentation characterized by hyperpigmented maculae with pathognonomic irregular and serpinginous borders classically described as the "Coast of Maine," which are mainly found on the anterior and posterior neck, gluteal region, thorax, back, shoulder and pelvis. 2 The most common feature of the syndrome, fibrous dysplasia (FD) which can be monoostotic (single bone involvement) or polyostotic (multiple bone involvement) is characterized by the replacement of medullary bone with a poorly organized fibrous tissue containing trabeculae of immature bone. 2, 6 The third component of the classical triad is hyperfunctioning endocrinopathies which may include precocious puberty, hyperthyroidism, pituitary adenomas, primary adrenal hyperplasia, hypophosphatemia and ovarian cysts. 5 Gonadotropin independent precocious puberty is the most common endocrinopathy which is more common in girls. Other endocrine and nonendocrine organs like the heart, adrenal, thyroid, pituitary and liver can be involved. 1, 2 Rarely, manifestations of rickets and osteomalacia are present in children and adolescents diagnosed to have fibrous dysplasia. These patients have the characteristic biochemical profile of hypophosphatemia with phosphaturia, attributed to the hypersecretion of a phosphatonin fibroblast growth factor 23 (FGF23) from dysplastic bone lesions. 1, 2, 4 We present a case of the classic triad of MAS along with hypophosphatemic rickets. Only a few cases have been reported with simultaneous involvement of precocious puberty and hypophosphatemic rickets along with fibrous dysplasia and café-au-lait macules.
CASE
A 3½-year-old girl was admitted for evaluation of enlargement of both breasts along with vaginal bleeding for 2½ months. The girl was born of a non-consanguineous marriage, full-term, normal vaginal institutional delivery with cephalic presentation and cried immediately after birth. There were no feeding difficulties, no jaundice, no lactose intolerance and no developmental delay. There were no other chronic illnesses, no decreased appetite, galactorrhea, hypothyroidism, hypocortisolism, head trauma, meningitis, seizures, encephalitis, visual field defect, brain surgery, radiation, defective smell, difficulty in vision, difficulty in walking or deformity of extremities. There was no significant maternal drug intake.
Anthropometry
The following is her anthropometric data: Height: 90 cms (3-10 percentile), Arm Span: 88 cms, Mean Parental Height: 161.5 cm, Weight: 15 kg (50-75 percentile).
Physical Examination
Her physical exam revealed a conscious, fully oriented female child, with feminine facies and body contour, antalgic gait, thyroid gland not enlarged, normal hair distribution, Marshall and Tanner stage: A0 P1 B3, There was no hirsutism, nor clitoromegaly. Her pulse was 70/min, regular, with normal peripheral pulses; BP was 90/52 mm Hg, with no postural fall. Chest, cardiovascular, abdominal, and neurologic examinations were normal. There was tenderness over the left thigh with restriction in movement of the left hip joint. There were café-au-lait spots on the left side of the face. (Figure 1 ). 
Laboratory Investigations
Basal levels of luteinizing hormone (LH) and folliclestimulating hormone (FSH) were low (0.4 and 0.7 IU/L, respectively), with no change in response to stimulation by 100 mg of triptorelin (Table 1) . Pelvic ultrasound revealed left ovarian cysts measuring 3.70 and 3.4 cm. The uterus was enlarged with a length of 4.6 cm (normal ≤3 cm) and had a prominent endometrium.
X-ray of the lower limbs showed fibrous dysplasia involving the left femur ( Figure 2 ) and skull x-ray showed ground glass appearance of the left orbit. (Figure 3 ).
Other investigations revealed normal serum calcium (9.4 mg/dL), phosphorus was reduced to 2 mg/dL (normal 2.7-4.5 mg/dL), markedly elevated serum alkaline phosphatase 1184 IU/L (normal 145-420 U/L), normal potassium (4.1 meq/L), normal 25(OH), D level of 42 nmol/L (25-120 nmol/L). Parathormone level was mildly elevated at 62 pg/ml (normal 11-54 pg/ml), fibroblast growth factor (FGF-23): 254.3 RU/mL.
Arterial blood pH was 7.394 and urine pH was 5.3. Urine examination for glucose and amino acids was negative ruling out the possibility of proximal renal tubular acidosis.
After evaluation, she was diagnosed with McCuneAlbright syndrome with hypophosphatemic rickets, and was started on letrazole along with phosphate supplement and calcitriol.
Basal levels of luteinizing hormone (LH) and folliclestimulating hormone (FSH) were low (0.4 and 0.7 IU/L, respectively), with no change in response to stimulation by 100 mg of triptorelin (Table 1 ). 
DISCUSSION
McCune Albright Syndrome is a rare, multisystem disorder with female predilection, first described separately by Donovan McCune and Fuller Albright in 1937, in a group of children presenting with café-au-lait maculae, bone deformities and hyperfunctioning endocrinopathies attributed to an activating mutation of Gs gene. 1 The syndrome is caused by a post-zygotic somatic mutation in GNAS1 gene located on 20q13-13.29, encoding for the alpha subunit of the stimulatory G protein, resulting in the constitutive activity of the gene products. Normally, on binding of ligands to the receptor, the Gsα gets stimulated and dissociates from the receptor to activate adenylyl cyclase enzyme to increase the production of cAMP which mediates further signaling cascade. On inactivation, Gsα again reattaches with receptor for ligand mediated reactivation. 1, 2 The clinical presentation is heterogeneous with involvement of endocrine and non-endocrine organs depending on the number and the types of cells carrying the GNAS1 mutation. 2 Similarly, the syndrome has varied evolution and progression. Usually the syndrome is diagnosed on the basis of the classic triad of fibrous dysplasia which develops due to the mutation in osteoprogenitor cells without differentiation, hyperfunctioning endocrinopathies along with isosexual precocious puberty and café-au-lait maculae mostly developing between the age of 4 months to 2 years but can be present at birth. 2, 8 Fibrous dysplasia usually manifests during the first decade of life as aching pain, pathological fractures, limb asymmetry and deformities and is usually polyostotic, commonly involving the long bones, ribs and skull. Involvement varies greatly in severity from small, asymptomatic areas only detected on bone scan to highly disfiguring lesions leading to the pathological fractures and impingement of vital organs. 7 Sometimes MAS is associated rarely with hypophosphatemic rickets, a group of disorders with the common denominator of defective renal phosphate reabsorption leading to phosphaturia and hypophosphatemia. The most common form is X-linked hypophosphatemic rickets. Acquired forms of hypophosphatemic rickets are associated with mesenchymal tumors, hemangiomas and soft-tissue tumors. 1, 2 Hypophosphatemic rickets associated with MAS is caused by the overproduction of the phosphatonin FGF23 by the cells in the dysplastic region of the bone. Our case might be considered among the 65-80% of CVST cases with one or more identifiable causes. Here, the main cause being elevated triglyceridemia which may have played a role in increasing our patient's thrombotic risk. This highlights a potential direct association between CVST and hypertriglyceridemia in the absence of other pre-disposing factors. If such a relationship between hypertriglyceridemia and CVST were to be found, new diagnostic measures might be warranted and this may also have an implication on the risk of recurrence and duration of anticoagulation in this group of patients.
CONCLUSION
Severe hypertriglyceridemia may trigger CVST. In this rare case study, hypertriglyceridemia was the only predisposing risk factor for developing CVST. Our case highlights the need for clinicians to consider CVST among patients with uncontrolled hypertriglyceridemia. New diagnostic measures may become necessary which may also have an implication on the risk of recurrence and duration of anticoagulant therapy in this group of patients.
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